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Negative selectionAbstract Insulin-dependent diabetes mellitus (IDDM) is considered to be a consequence of
unchecked auto-immune processes. Alterations in immune system responses are thought to be
the cause of the disease, but the possibility that altered metabolite levels (glucose) can establish
the disease by speciﬁcally acting on and altering thymus stroma functions has not been investigated.
Therefore, the direct effect of hyperglycaemia (HG) on central tolerance mechanisms as a causative
agent needs to be investigated.
ª 2013 Tehran University of Medical Sciences. Published by Elsevier Ltd. All rights reserved.Open access under CC BY-NC-ND license.Introduction
Environmental factors play a major role in establishing non-
insulin-dependent diabetes mellitus [1,2]. However, the role
of environmental factors in the development of type I diabetes
(T1D) is more obscure, particularly with regard to health and a
non-predisposed background [3].
The non-obese diabetes (NOD) strain of mice is a well-
established model system, whereby diabetes development initi-
ates due to reversible insulitis and then proceeds through an
irreversible stage, which leads to inﬁltration and destruction
of b cells [4,5]. The process is thought to be initiated by the pre-
sentation of autoantigens by dendritic cells (DCs) in local
draining lymph nodes of the pancreas [4].ratory of Molecular Immunology
amedov Str., Almaty 050012, Kaz
. Abramova).
niversity of Medical Sciences. Pub
h/
/j.jmhi.2013.04.001Some evidence has shown that strong psycho-emotional
stress and trauma can contribute to disease development, but
their effects have mainly been investigated as exacerbating fac-
tors in an already established disease [1,2]. In addition, it is
well documented that during stress, glycaemic levels rise and
persist as long as the stress remains [1,2].
Streptozotocin (STZ)-induced hyperglycaemia (HG) was
shown to increase thymocyte survival in ovalbumin (OVA)-
speciﬁc T cell receptor (TCR)-transgenic mice compared to
controls [6]. However, the role of the thymus in this process
was not investigated.
Although predisposition to this disease plays a signiﬁcant
role, one recent study has shown that environmental factors
can trigger reversible immune alterations in mice with a nor-
mal background [7]. Due to STZ-induced pancreatic islet loss,
defective immunosuppressive functions of T regulatory cellsand Immunobiotechnology, M.A. Aitkhozhin Institute of Molecular
akhstan. Tel.: +7 727 2937092; fax: +7 727 2921947.
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administration [7]. Moreover, alterations in the overall thymo-
cyte composition were observed, where the percentage of
CD4+ SP thymocytes was increased at 30 days after HG
establishment compared to control mice [7].
The hypothesis
Mechanisms of central tolerance together with mechanisms of
peripheral tolerance provide a way for avoiding life-threaten-
ing conditions through the control of the appearance or expan-
sion of autoreactive clones in the periphery, respectively [8].
Altered architecture, atrophy and mast-cell inﬁltration of the
thymus in HG conditions have been reported [9]. In addition,
implantation of a thymus from NOD mice into normal mice
induces disease development [10].
The hypothesis presented here is that HG can be a primary
triggering event in insulin-dependent diabetes mellitus
(IDDM) development through effects on thymic stroma func-
tion and in particular by affecting medullary thymus epithelial
cells (mTECs) during negative selection.
Glucose transporters (GLUTs) comprise a group of Na+-
independent facilitative glucose transport proteins [11]. Glu-
cose uptake by lymphocytes is known to be a source of energy
for cells, but the glucose metabolism pathway also interacts
with other pathways, where it can directly and indirectly mod-
ulate downstream functions [12]. However, the expression of
GLUTs in thymus epithelial cells (TECs), and particularly
mTECs, has never been explored, and therefore their role in
modulating mTEC functional capacity remains to be
determined.
If the proposed hypothesis is true, then it is possible not
only that IDDM is a consequence of tolerance breakdown,
but also that HG per se can lead to immune dysregulation
and disease manifestation. This hypothesis has been suggested
in previous work [6]; however, the direct inﬂuence of HG on
thymic stroma function was not investigated.
In a previous study, antiapoptotic effects of HG on
CD4+CD8+ DP thymocytes as well as the EL-4 thymoma
cell line were observed [6]. This investigation was performed
in vitro as well as in vivo using surrogate autoantigen OVA
transgenic mice. In that study, an increase in the expression
of GLUT1–GLUT4 on thymocytes in response to HG was ob-
served [6]. However, the effect of stromal cells in this work was
not addressed.
Several questions arise:
1. What types of GLUTs do TECs express? Does HG affect
the expression?
2. What is the contribution of different types of GLUTs in
mTEC function? If GLUT overexpression affects negative
T-cell repertoire selection, which can be assessed using
TCR-transgenic mice, then does GLUT overexpression
alter tissue-restricted antigens (TRAs) presented in the thy-
mus not only quantitatively, but also qualitatively? Are
pancreas-associated antigens present in these conditions
and at what extent?
3. What is the contribution of DCs in the process of negative
selection under HG conditions? Which of them – TEC or
DC (resident or circulating) – is responsible for the out-
comes of negative selection under HG conditions?4. In the case of humans, why does primary insulin adminis-
tration under HG conditions cause remission and why is
the remission reversible? It is widely accepted that after pri-
mary insulin administration, a honeymoon phase occurs;
the widely accepted basis for it is the rest of beta cells
and their subsequent performance for a period of time
[13]. However, auto-immune processes are ongoing and
the immunologic basis for remission is poorly understood
[13]. The contribution of suboptimal glucose levels during
insulin therapy to the course of this auto-immune disease
is also not fully understood, and the inﬂuence of HG on
TECs and their function will require further exploration.
5. If altered GLUT expression in thymic stroma causes an
auto-immune condition, then will the reactions be directed
to the pancreas or occur in a more generalised pattern?
Evaluation of the hypothesis
Beta cells of STZ- or alloxan-treated mice die by irreversible
damage due to the generation of reactive oxygen species and
the cellular remnants are processed by antigen-presenting cells
(APCs), and in particular DCs [13]. However, several experi-
ments have indicated that circulating non-resident DCs can
take up autoantigens from the periphery and present them to
thymocytes undergoing selection processes in the thymus
[14]. Therefore, pancreatic antigens can be provided to thymo-
cytes by circulating DCs in these models as well, and this issue
should be considered when these models are used for experi-
mentation. In addition, if stress-induced or alimentary HG
models are used, then an excessive amount of circulating insu-
lin can alter the mechanisms of central tolerance [14]. It is also
critical to investigate these processes in mouse strains that are
not initially predisposed to auto-immune diseases.
The principle of the approach for studying this hypothesis
is to imitate GLUT expression levels and the subsequent glu-
cose uptake by TECs to the extent at which it occurs under
conditions of HG and investigate the direct cell-autonomous
effects of altered glucose uptake on TEC function. One possi-
ble experimental approach is based on the assumption that
HG causes increased expression of particular GLUTs in thy-
mic stroma cells. This includes:
1) Evaluation of the expression of different GLUTs in thy-
mus stromal cells under conditions of normal glycaemia
and HG in connection with pan-cortical (CDR1, Ly51
and b5t [15]) and pan-medullary (UEA-1 and Aire
[15]) TEC markers. These differences may be cell-type-
speciﬁc, and therefore additional investigations of one
speciﬁc type of TEC (mTEC) will be considered. The
most prominent alteration (in particular GLUT expres-
sion) will be taken into account and will serve as the
basis for further construction of a mouse model.
2) Creation of mice with increased GLUT expression in
thymic stroma to imitate speciﬁc levels of glucose uptake
under HG conditions.
To investigate direct cell-autonomous effects of increased
GLUT expression in thymic stroma and to exclude the contri-
bution of secondary processes (i.e., when possible alterations
in thymus stroma function are secondary to the effect of HG
Figure 1 The principal constructs. One mouse strain is ROSA26 YFP, which contains the second construct as depicted (not to scale).
The second mouse carries the complementing construct. The progeny will contain the desired genetic construct that results from the cross.
Hyperglycaemia alters thymic epithelial cell function 67on other tissues), it is better to address GLUT overexpression
directly on thymic stroma. One approach can be to create
transgenic mice with an extra copy of a GLUT gene under
the control of the thymus-speciﬁc FOXN1 promoter [15]. It
is also possible to cross mice expressing Cre recombinase under
the control of the FOXN1 promoter with mice expressing the
extra copy of a GLUT gene under the control of an inducible
promoter with a loxP-ﬂanked STOP cassette, which prevents
expression in non-Cre-expressing tissues (i.e., thymus). This
will allow for GLUT expression only in the thymus and only
at the desirable period of time. Moreover, this will be particu-
larly useful if an age-dependent inﬂuence of HG on thymo-
cytes is investigated.
Extra-GLUT may not lead to a high level of GLUT in the
plasma membrane, as its trafﬁcking is tightly regulated by
insulin and as GLUT expression is regulated at multiple levels
[16] or constitutively expressed (e.g., GLUT1) [11].
Theoretically, the level of membrane receptor (if GLUT4 is
used; the decision is made on the investigation of GLUT levels
on TECs) can be increased if a mutation is introduced into
TELEY and FQQI motifs as previously shown [17] (though
this was conducted in adipocytes), which can give rise to in-
creased surface expression of GLUT4 on the plasma mem-
brane. To verify successful excision of a target sequence by
Cre recombinase, mice bearing ROSA26-YFP can be applied
(Fig. 1) [18].
1) Investigation of the functional capacity of thymic
stroma. If standard TCR-transgenic (OVA peptide, hae-
magglutinin-speciﬁc, etc.) mice are crossed with strains
expressing this antigen not only in the thymus, but also
in peripheral tissues, such as under the control of rat
insulin promoter (RIP) or ubiquitous promoters, then
the results will be generated from the ‘background’ of
circulating DCs, which take up such antigens and deliver
them to the thymus [6]. Based on a rough approxima-
tion, the contribution of circulating DC can be
neglected. It is better to use a thymus from neo-self-anti-
gen-expressing mice (experimental mice should be
expressing extra-GLUT in the thymic stroma) and trans-
fer it to nude TCR-transgenic mice not expressing the
neo-self-antigen elsewhere in order to avoid contribution
from the periphery and to observe pure, ‘thymus-resi-
dent cell’-mediated negative selection. Alternatively,
hybrids from TCR-transgenic mice and mice exclusivelyexpressing neo-self-antigens in the thymus can be used.
The readout in either system will be assessed by neo-
self-antigen-reactive clones.
Discussion
If the experimental evidence conﬁrms this hypothesis, then the
role of HG in priming immune alterations at the level of thy-
mus stroma function will be established.
The degree of irreversibility of alteration in thymic stroma
functions depends on the longevity ofHGpersistence.However,
mTECs have a fast turnover [19], and if this is due to altered
function, then one question that arises is why reversion of diabe-
tes is not observed after the cells are replaced? It is possible that
HG affects TEC precursors with a longer life span or creates an
unknown state when TECs of previous generations (affected by
HG) inﬂuence the functions of the TECs in the next generation,
possibly through abnormal directive instructions.
It should be noted that in the proposed approach for eval-
uating the inﬂuence of HG on the TEC, the emphasis is made
on OVA-TCR transgenic or other surrogate model systems as
readouts. Therefore, the proposed study is intended to explore
the phenomenon of these observations, as the molecular mech-
anisms are obscure. The readout used can include the synthesis
of autoantigens as well as their surface expression. Considering
the role of autophagy in major histocompatibility complex II
(MHCII) loading in TECs [20], it is tempting to speculate
the involvement of this process; however, the mechanism by
which selectivity of (pro)insulin processing in these circum-
stances occurs is currently not known. If this process is in-
volved, then the level at which TEC precursors become
impaired and the basis for this impairment are also unknown.
We propose that HG should affect an entity that is long-
lived in the thymus or must initiate self-propagating pathologic
mechanisms. In addition, it seems that the longevity or severity
of HG should be sufﬁcient for initiating pathologic processes
(e.g., alimentary HG that is limited in severity and duration
does not cause diabetes).
This research can be further expanded by analysing
more narrowly deﬁned questions, such as how does HG
inﬂuence auto-immune regulator-mediated gene expression?
What is the distribution and density of particular TRAs
on mTECs?
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What do we already know about the subject?
IDDM is considered to occur as a consequence of un-
checked auto-immune responses. The role of HG in
the establishment of the disease at the level of direct ef-
fects on thymus epithelial cells and their function is not
well understood.
What does your proposed theory add to the current
knowledge available, and what beneﬁts does it have?
If the proposed hypothesis is true, then it suggests that
IDDM is a consequence of not only tolerance break-
down, but also environmental processes, such as
stress-induced HG, which can lead to immune dysreg-
ulation and disease manifestation. A previous study
has provided evidence for increased autoreactive clone
survival under HG conditions, which also raised the
question of a cause–effect relationship between HG
and the auto-immune state [6]; however, the inﬂuence
of HG on thymic stroma function is unclear.
Among numerous available studies, what special further
study is proposed for testing the idea?
The main approach of this study is to imitate speciﬁc
GLUT expression levels observed under conditions
of HG on thymic stroma in order to assess the direct
effects on the efﬁciency of central tolerance mecha-
nisms in various settings.References
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